Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The application of medical decision analysis to genetic testing: an introduction.

Genetic testing - 1 Jan 1999

McConnell L M, Goldstein M K

Abstract excerpt

The availability of genetic tests to diagnose or predict Alzheimer disease (AD) causes a shift in the way people think about the condition and how they assess the options available to them. Decision analysis in a quantitative approach for dealing with the uncertainties inherent in many medical decisions, including decisions about genetic testing. Decision analysis does not guarantee a good outcome, but aims to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Decision Making
Share to Decision Support Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Source

Identifiers

PMID: 10464579
DOI: 10.1089/gte.1999.3.65

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The application of medical decision analysis to genetic testing: an introduction.PMID 10464579Read ↗

Decision analysis and Alzheimer disease: three case studies.Semantic proximity Read ↗

A philosophical critique of decision analysis as a tool in genetic testing.Semantic proximity Read ↗

When algorithms replace biologists: A Discrete Choice Experiment for the valuation of risk-prediction tools in Neurodegenerative DiseasesSemantic proximity Read ↗

Consumer preferences for the predictive genetic test for Alzheimer disease.Semantic proximity Read ↗

Understanding probabilistic risk in predisposition genetic testing for Alzheimer disease.Semantic proximity Read ↗

In silico study of medical decision-making for rare diseases: heterogeneity of decision-makers in a population improves overall benefitSemantic proximity Read ↗

A theory of medical decision making and health: fuzzy trace theory.Semantic proximity Read ↗

Development of Breast Cancer Choices: a decision support tool for young women with breast cancer deciding whether to have genetic testing for BRCA1/2 mutations.Semantic proximity Read ↗

Genetic susceptibility testing versus family history-based risk assessment: Impact on perceived risk of Alzheimer disease.Semantic proximity Read ↗

A Simulation-Based Discrete Choice Experiment Framework for Alzheimer’s Disease-Modifying Therapy Implementation: Methodology and Interactive Decision Support ToolSemantic proximity Read ↗

Survival or Mortality: Does Risk Attribute Framing Influence Decision-Making Behavior in a Discrete Choice Experiment?Semantic proximity Read ↗

Psychological Impact of Predictive Genetic Testing in VCP Inclusion Body Myopathy, Paget Disease of Bone and Frontotemporal Dementia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.